Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES $ 1,025 $ (1,442)
INVESTING ACTIVITIES    
Purchase of medical equipment and property (1,213) (1,015)
Proceeds from sale of medical equipment and property 1,076 1,525
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES (137) 510
FINANCING ACTIVITIES    
Principal payments on revolving credit facility, term loans and capital lease obligations (2,790) (6,413)
Cash proceeds from revolving credit facility 4,099
Debt issuance costs (25)
Common stock repurchased to satisfy statutory withholding on employee stock based compensation plans (20)
Common stock repurchased as part of Repurchase Program (83)
Cash proceeds from stock plans 46 87
NET CASH USED IN FINANCING ACTIVITIES (2,827) (2,272)
Net change in cash and cash equivalents (1,939) (3,204)
Cash and cash equivalents, beginning of period 3,469 3,398
Cash and cash equivalents, end of period $ 1,530 $ 194